Navigation Links
University of Plymouth invests in dental research
Date:1/14/2010

The University of Plymouth is to provide 500,000 funding for the Peninsula Dental School to pursue three important areas of research in partnership with the University, it was announced today.

The first area of research will cover statistical epidemiology in oral health, including the review of published evidence and the creation of new approaches to understanding the complexity of dental research data.

The second will look at the use of virtual reality and psychological approaches to tackle dental anxiety. The research will examine the extent to which virtual reality could be used to ease anxiety both before and during treatment.

The third area of research will consider nanotechnology, toxicology and dentistry. Nanopowders and nanotechnology are used widely in the latest generation of dental filling materials. They are also found in the surfaces of implants, dental tissue engineering and toothpastes and their use has been driven by the demand for materials that are aesthetically pleasing and the desire to move away from a reliance on mercury containing materials such as dental amalgam.

However, there is a possibility that engineered nanomaterials may act as endocrine disruptors, could be genotoxic (which means that they could affect the integrity of cells which in some cases are mutagenic or carcinogenic) and may prove to be toxic to the wider environment. This area of research will consider the issues in conjunction with the European Centre for the Environment and Human Health, which is part of the Peninsula Medical School.

David Moles, Professor of Oral Health Services Research and Director of Postgraduate Education and Research at the Peninsula Dental School, commented: "We have chosen three areas of research that require additional and focused study, and which will ultimately be of benefit to dental practitioners and their patients. We are very grateful to the University of Plymouth for this funding and we loo
'/>"/>

Contact: Andrew Gould
andrew.gould@pms.ac.uk
44-139-268-6107
The Peninsula College of Medicine and Dentistry
Source:Eurekalert

Page: 1 2

Related biology news :

1. University of Pittsburgh researchers launching trial of new osteoporosis drug
2. New spider species discovered by University of Haifa scientists
3. University Hospitals Case Medical Center testing gene therapy for Alzheimers disease
4. Uniform method to interpret autism spectrum disorders is defined at Ben-Gurion University
5. Michigan State University study sheds light on microscopic flower petal ridges
6. Boston University reseachers develop faster, cheaper DNA sequencing method
7. University of Maryland School of Medicine receives $30 million to coordinate stem cell consortium
8. Case Western Reserve University grants option to startup Thermalin Diabetes Inc.
9. Lehigh University professor receives Astellas Award for arsenic groundwater remediation efforts
10. University of Texas Southwestern Medical Center researcher wins Avanti Award in lipids
11. University of Washington professor garners Avanti Young Investigator Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2014)... Kessler Foundation has been named awardee of a ... of Defense Spinal Cord Injury Research Program. Gail ... randomized, double-blinded, controlled, multi-site clinical trial, which will ... after spinal cord injury. Dr. Forrest is assistant ... Kessler Foundation. Two additional sites will participate - ...
(Date:4/17/2014)... in about one per eight hundred births, Down syndrome ... genetic cause of intellectual disability. It results from a ... third copy of chromosome 21 (1% of the human ... team in the Department of Genetic Medicine and Development ... published in Nature , shed light on how ...
(Date:4/17/2014)... about eight years ago, Katia Silvera , a postdoctoral ... were on a field trip in a mountainous area in ... never seen before. , Unable to identify it, they contacted ... turned out to be an unnamed species. So Carnevali recently ... "Lophiaris" is the genus name, comprising about 40 species in ...
Breaking Biology News(10 mins):Kessler Foundation awarded Department of Defense grant for spinal cord injury research 2Trisomy 21: How an extra little chromosome throws the entire genome off balance 2Trisomy 21: How an extra little chromosome throws the entire genome off balance 3Orchid named after UC Riverside researcher 2Orchid named after UC Riverside researcher 3
... Angeles, London, New Delhi, Singapore and Washington DC (16 September, ... Journal of Dental Biomechanics (JDB), the second open access ... and the Hindawi Publishing Corporation. The Journal of ... to the study of biomechanics as it relates to dentistry. ...
... More than 125 years ago Charles Darwin first reported ... not the day and this week, scientists are reporting ... These rhythmic growth spurts, and the ability of plants to ... involved in circadian rhythms the "biological clock" genes that ...
... he discovered a gene that controls innate fear in ... the same gene promotes "helicopter mom" behavior in mice. ... female animals to protect newborn pups and interact cautiously ... concentrated in the amygdala, a key region of the ...
Cached Biology News:SAGE-Hindawi launch Journal of Dental Biomechanics 2'Biological clock' genes control plant growth 2No helicopter moms among Rutgers mutant mice 2No helicopter moms among Rutgers mutant mice 3
(Date:1/15/2014)... 2014 The Microcompetition with Foreign DNA theory ... of these latent viruses is the Epstein Barr Virus (EBV), ... arthritis (RA) is a chronic inflammatory disease that destroys the ... that RA patients have high concentrations of EBV DNA in ...
(Date:1/15/2014)... TAIPEI , Jan. 15, 2014 TaiGen Biotechnology ... an exclusive agreement with R-Pharm, a leading Russian pharmaceutical ... in the Russian Federation , ... Commonwealth Independent States (CIS). Nemonoxacin is a novel antibiotic for ...
(Date:1/14/2014)... Calif. , Jan. 14, 2014 As pet owners drew ... doubt many of them wrote: "Take better care of my furry ... even designer clothes and top-brand carrying cases to take the little ... parents might also feel compelled to buy some pricey toys at ...
(Date:1/14/2014)... 2014 In recent years, growing suspicion ... in product development and promotion has led to unprecedented ... fueled by concerns about the insidious impact of commercialization ... spectacular fines to the world’s biggest pharmas for illegal ...
Breaking Biology Technology:Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 3TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 2TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 3TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 4New Year's Resolution: Give Pets the Gift of Top-Notch Health Care 2The Sunshine Act: Necessary Regulation or Unnecessary Dysregulation? New Life Science Webinar Hosted by Xtalks and IRB Services 2The Sunshine Act: Necessary Regulation or Unnecessary Dysregulation? New Life Science Webinar Hosted by Xtalks and IRB Services 3
... Laboratories, pathologist, Ronald L. Weiss, MD, MBA, FCAP, received ... Pathologists at CAP ,11, the organization,s annual meeting, held ... the award honors members "who have made a broad ... of pathology." (Logo: http://photos.prnewswire.com/prnh/20110915/SF69370LOGO ) ...
... 2011 NewCardio, Inc., (OTC BB: NWCI) a cardiovascular ... Clinilabs, will utilize QTinno®, NewCardio,s automated cardiac safety solution, ... new drug under development for a central nervous system ... one important aspect of the trial. Clinilabs, ...
... 2011 Orexigen® Therapeutics, Inc. (Nasdaq: OREX ), ... announced financial results for the third quarter of 2011. For ... net loss of $4.6 million, or $0.10 per share, as ... per share, for the third quarter of 2010. As of ...
Cached Biology Technology:ARUP Laboratories' Pathologist, Ronald L. Weiss, MD, Honored With Lifetime Achievement Award for Contributions to Patient Care and Pathology 2Clinilabs will Conduct Phase 1 Trial Using QTinno® 2Clinilabs will Conduct Phase 1 Trial Using QTinno® 3Clinilabs will Conduct Phase 1 Trial Using QTinno® 4Clinilabs will Conduct Phase 1 Trial Using QTinno® 5Orexigen® Therapeutics Reports Third Quarter Financial Results 2Orexigen® Therapeutics Reports Third Quarter Financial Results 3Orexigen® Therapeutics Reports Third Quarter Financial Results 4Orexigen® Therapeutics Reports Third Quarter Financial Results 5
... ISO 9001:2000 Certified USDA Research Registered OLAW ... Training AALAS Certified Technicians ... GLP Documentation Upon Request Focus ... for all your custom immunology service needs. ...
Human IL-17D Affinity Purified Polyclonal Ab...
BBS/Glycerol/Casein Block and Diluent - 10X Concentrate, 1 L...
... peptide derived from an internal region of ... of rapamycin FRAP RAFT1 RAPT1). Specificity: ... On Western blots it identifies the target ... (positive control: HEK293 cell lysates). Based on ...
Biology Products: